超高效液相色谱-静电场轨道阱高分辨质谱法测定法莫替丁及其制剂中的痕量N-亚硝基二甲胺

建立了测定法莫替丁及其制剂中N-亚硝基二甲胺(NDMA)含量的超高效液相色谱-静电场轨道阱高分辨质谱法(UHPLC-Orbitrap HRMS)。样品以甲醇作为提取溶剂,经涡旋混匀、恒温振荡、高速离心、微孔过滤后进行液相色谱-质谱(LC-MS)分析。采用ACE EXCEL 3 C_(18)-AR(150 mm×4.6 mm,3μm)色谱柱,以0.1%甲酸水溶液和0.1%甲酸乙腈为流动相梯度洗脱分离,流速为0.50 mL/min,柱温为30℃,自动进样器温度为4℃,设置六通阀切换保护质谱系统。质谱分析采用ESI离子源,正离子平行反应监测(PRM)扫描模式,外标法定量。NDMA在1.00～100.00 ng/mL范围内线性良好,相关系数(r)为0.999 7,检出限和定量下限分别为0.20 ng/mL和1.00 ng/mL,在法莫替丁及其制剂中的平均回收率为98.5%～108%,相对标准偏差(RSD)为2.3%～6.7%。将该法用于47批供试品中NDMA的测定,在1批法莫替丁原料和2批制剂中检出NDMA,其含量超过限度规定。该方法灵敏、准确、操作简便,可用于法莫替丁及其制剂中NDMA的测定。     

液相色谱-串联质谱法测定紫菜中三种三取代有机锡化合物

建立了液相色谱-串联质谱(LC-MS/MS)同时测定紫菜中三甲基锡(TMT)、三苯基锡(TPhT)和三丁基锡(TBT)的分析新方法。样品用二氯甲烷-乙酸乙酯(1∶1,V/V)混合溶剂进行超声提取,提取液经氮吹至近干,并用甲醇和水混合溶液(7∶3,V/V)定容,经活性炭净化。采用ZORBAX Eclipse plus C18色谱柱分离,流动相为甲醇-0.1%甲酸溶液(55∶45,V/V),流速为0.3mL/min。在正离子模式下采用多重反应模式(MRM)进行监测。有机锡化合物在1~100ng/mL浓度范围内线性良好,相关系数在0.9902~0.9918之间,TMT、TPhT和TBT的检测限分别为0.2ng/mL、0.4ng/mL和0.2ng/mL。在25、75ng/mL两个添加水平下回收率在72.3%~98.0%之间,其相对标准偏差均小于8.1%。该方法可用于紫菜中三种三取代有机锡化合物的同时测定。     

液相色谱-串联质谱法同时测定人血清中皮质酮与皮质醇

建立了同时测定人血清中皮质酮和皮质醇的液相色谱-串联质谱法。血清经正己烷除脂净化、叔丁基甲醚提取后,以乙腈-0.1%甲酸溶液(含0.01 mol/L甲酸铵)为流动相,流速为0.3 mL/min。用Agilent E-clipse Plus-C18色谱柱(150 mm×2.1 mm,3.5μm)分离,正离子模式下进行串联质谱检测。皮质酮和皮质醇浓度在0.5～200 ng/mL范围内线性关系良好,相关系数(r2)分别为0.999 7、0.999 4。皮质酮和皮质醇分别在5.0、25.0、75.0 ng/mL和0.5、2.5、10.0 ng/mL 3个加标水平下的平均回收率为86.6%～102.7%,相对标准偏差不大于7.1%,检出限分别为0.1 ng/mL和0.05 ng/mL。该方法操作简便、灵敏度高、重现性好、定性定量准确,适用于同时测定血清中的内皮质酮和皮质醇。     

超高效液相色谱-串联质谱法测定水产品中三聚氰胺残留量

建立超高效液相色谱-串联质谱(UPLC-MS/MS)快速测定水产品中三聚氰胺残留的方法.采用ACQUITY UPLC BEH HILIC色谱柱(100 mm×2.1 mm, 1.7 μm),流动相为乙腈-0.5 mmol/L乙酸铵溶液(0.1%甲酸),流速为0.3 mL/min.采用电喷雾质谱检测,以正离子模式5 min完成质谱分析.实验结果表明,三聚氰胺在水产品中的检测限为0.05 mg/kg,在0.05～0.50 mg/kg添加水平时的加标回收率为63%～90%,测定结果的相对标准偏差均小于7.2%(n=6).     

全自动在线固相萃取-二维高效液相色谱与质谱联用测定辣椒油中苏丹红

建立了全自动在线固相萃取-二维高效液相色谱与质谱联用快速测定辣椒油中的苏丹红Ⅰ,Ⅱ,Ⅲ,Ⅳ的方法。样品经乙腈和二氯甲烷萃取后,在一维色谱柱(Acclaim PAⅡ,150 mm×3.0 mm×3μm)上分离出苏丹红,通过阀的分段切换,依次富集在SPE柱(Acclaim 120 C18,10 mm×4.6 mm×5μm)上,在线完成净化和萃取富集;再通过阀切换将它们转移至二维色谱流路,在Acclaim 120 C18色谱柱(100 mm×2.1 mm×2.2μm)上分离检测。一维色谱以水-乙腈-甲醇/四氢呋喃(1∶1,V/V)为流动相,进样体积20μL,0.6 mL/min流速梯度洗脱和紫外-可见检测器(λ=254 nm)监测分离状况;二维色谱以水-乙腈-甲酸/乙腈(1∶1000,V/V)为流动相,0.3 mL/min流速梯度洗脱,采用单四极质谱仪,选择离子方式检测。整个分析流程27 min即可完成。4种苏丹红的保留时间的相对标准偏差均小于0.1%,色谱峰面积的相对标准偏差均小于2%(n=7);在0.6～60μg/L范围内峰面积与进样质量浓度的线性相关系数均大于0.9958;加标回收率为50%～97%;方法检出限均小于0.2μg/L(S/N=3)。测定结果令人满意。     

甲卡西酮的LC-MS/MS定性定量分析方法

建立了LC-MS/MS法定性定量分析甲卡西酮。采用三重串联四极杆液质联用仪(LC/QQQ),AgilentZorbax Eclipse Plus C18色谱柱(100 mm×2.1 mm,1.8μm),流动相为0.1%甲酸-乙腈,梯度洗脱,流速为0.3mL/min。质谱应用ESI源、正离子模式、多反应监测(MRM)方式。在0.1～10 000 ng/mL质量浓度范围内线性关系良好,r2=0.999 8,日内与日间保留时间和峰面积的相对标准偏差不大于5.28%,检出限为0.04 ng/mL,回收率为95.6%～100.7%。该方法适用于甲卡西酮的定性、定量分析。     

液相色谱-串联质谱法测定大鼠血浆中福斯克林

建立了测定大鼠血浆中福斯克林的液相色谱-串联质谱法(LC-MS/MS).血浆样品经液-液萃取后,以V(甲醇):V(10 mmol/L 醋酸铵):V(甲酸)=75:25:0.1为流动相,用Hypersil ODS柱分离,流速0.8 mL/min(柱后分流50%),通过电喷雾离子化四极杆串联质谱,以多反应监测方式(MRM)检测.用于定量分析的离子分别为m/z 428/375(福斯克林)和m/z 494/369(格列本脲,内标).福斯克林血浆浓度测定方法的线性范围为0.8～800 μg/L; 日内、日间精密度(RSD)均小于10%;准确度(RE)小于±9%.每个样品测试时间4.5 min.应用此法测试了大鼠口服或静注福斯克林后的血药浓度.     

流动注射化学发光抑制法测定吡罗昔康

基于吖啶橙在氢氧化钠介质中能被高锰酸钾氧化产生较强的化学发光,吡罗昔康能强烈抑制其化学发光,建立了高锰酸钾-吖啶橙-吡罗昔康化学发光抑制测定吡罗昔康的新方法。吡罗昔康在1.0×10-5~7.0×10-4g/mL范围内与化学发光强度呈良好线性关系,方法的检出限为4.5×10-6g/mL,对1.0×10-5g/mL吡罗昔康连续进行6次测定的相对标准偏差为3.6%。     

超高效液相-串联质谱法同时测定蜂蜜中15种喹诺酮类药物残留

建立了蜂蜜样品中15种喹诺酮类兽药残留的超高效液相色谱-串联质谱检测方法。蜂蜜样品用磷酸盐缓冲溶液溶解提取后,用Oasis HLB固相萃取柱净化,超高效液相-电喷雾串联四级杆质谱检测,外标法定量。测定时用Acquity UPLC BEHC18色谱柱(50 mm×2.1 mm,1.7μm)分离,体积分数0.1%甲酸溶液-乙腈系统梯度洗脱,质谱测定采用多重反应监测(MRM)模式。15种喹诺酮类兽药的检出限均低于或等于1.0 ng/mL,回收率均在78.6%～112.9%范围内,相对标准偏差均在10%范围内。该方法各项指标均能满足国内外各项法规的要求,可用于蜂蜜样品中喹诺酮类药物残留的定量和定性检测。     

超高效液相色谱-串联质谱法测定注射用头孢曲松钠中2-巯基苯并噻唑的含量

建立了一种超高效液相色谱-串联质谱法（UPLC-MS/MS）测定注射用头孢曲松钠中2-巯基苯并噻唑（MBT）基因毒性杂质含量。样品经甲醇提取,50%(V/V)乙腈稀释后,采用ACQUITY UPLC HSS T3色谱柱（2.1 mm×100 mm, 1.8μm）分离,乙腈-0.05%(V/V)乙酸（80∶20, V/V）为流动相,电喷雾离子源（ESI）,多反应监测（MRM）负离子模式扫描,外标法定量。MBT在0.11～10.92 ng/mL范围内线性关系良好（r2=0.9989）,检出限为0.03 ng/mL,定量限为0.08 ng/mL,平均回收率为96.8%,相对标准偏差（RSD）不大于3.5%。采用该方法检测抽检的14个厂家63批次样品中MBT杂质含量,59批次样品中有MBT检出。该方法适用于注射用头孢曲松钠中MBT的定性和定量分析。     

A high‐performance liquid chromatography–tandem mass spectrometry method coupled with protein precipitation for determination of granisetron in human plasma and its application to a comparative pharmacokinetic study

A rapid, simple and validated method based on liquid chromatography coupled with tandem mass spectrometry (LC‐MS/MS) has been developed for the determination of granisetron in human plasma. Plasma samples were pre‐purified by protein precipitation procedure. The chromatographic separation was achieved with Synergi Polar‐RP (75 × 2 mm, 4 µm) column using a mixture of 5 mm pH4.0 ammonium formate and methanol (300:316, v/v) under isocratic conditions at a flow rate of 0.3 mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer in multiple reaction monitoring mode using positive electrospray ionization. The analysis time was about 2.5 min. The method was fully validated over the concentration range 0.1–10 ng/mL. The lower limit of quantification was 0.1 ng/mL. Inter‐ and intra‐batch precision was <6.1% and the accuracy was within 95.6–100.0%. The mean extraction recovery was 96.3%. Selectivity, matrix effect and stability were also validated. The method was applied to the comparative pharmacokinetic study of granisetron in Chinese healthy subjects. Copyright © 2014 John Wiley & Sons, Ltd.     

Simultaneous determination of amiloride and hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionisation

A new method for simultaneous determination of amiloride and hydrochlorothiazide by liquid chromatography/electrospray tandem mass spectrometry (LC/MS/MS) operated in positive and negative ionization switching mode was developed and validated. Protein precipitation with acetonitrile was selected for sample preparation. The analytes were separated on a Phenomenex Curosil-PFP (250x4.6 mm, 5 microm) column by a gradient elution with a mobile phase consisting of 0.15% formic acid solution containing 0.23% ammonium acetate and methanol pumped at a flow rate of 1.0 mL.min(-1). Rizatriptan was used as the internal standard (IS) for quantification. The determination was carried out on a Waters Quattro-micro triple-quadrupole mass spectrometer operated in multiple reaction monitoring (MRM) mode using the following transitions monitored simultaneously: positive m/z 230-->171 for amiloride, m/z 270-->158 for rizatriptan, and negative m/z 296-->205 for hydrochlorothiazide. The lower limits of quantification (LLOQs) were 0.1 and 1.0 ng.mL(-1) for amiloride and hydrochlorothiazide, respectively, which were lower than other published methods by using ultraviolet (UV), fluorimetric or mass spectrometric detection. The intra- and inter-day precision and accuracy were studied at three different concentration levels and were always better than 15% (n=5). This simple and robust LC/MS/MS method was successfully applied to the pharmacokinetic study of compound amiloride and hydrochlorothiazide tablets in healthy male Chinese volunteers.     

High-throughput determination of carbocysteine in human plasma by liquid chromatography/tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers

A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method to determine carbocysteine in human plasma was developed and fully validated. After methanol-induced protein precipitation of the plasma samples, carbocysteine was subjected to LC/MS/MS analysis using electrospray ionization (ESI). The MS system was operated in the selected ion monitoring (SRM) mode. Chromatographic separation was performed on a Hypurity C18 column (i.d. 2.1 mm x 50 mm, particle size 5 microm). The method had a chromatographic running time of 2.0 min and linear calibration curves over the concentration ranges of 0.1-20 microg/mL for carbocysteine. The lower limit of quantification (LLOQ) of the method was 0.1 microg/mL for carbocysteine. The intra- and inter-day precision was less than 7% for all quality control samples at concentrations of 0.5, 2.0, and 10.0 microg/mL. These results indicate that the method was efficient with a simple preparation procedure and a very short running time (2.0 min) for carbocysteine compared with methods reported in the literature and had high selectivity, acceptable accuracy, precision and sensitivity. The validated LC/MS/MS method has been successfully used to a bioequivalence study of two tablet formulations of carbocysteine in healthy volunteers.     

Development of an LC‐MS/MS method for quantification of kadsurenone in rat plasma and its application to a pharmacokinetic study

A sensitive and rapid LC‐MS/MS method was developed and validated for the determination of kadsurenone in rat plasma using lysionotin as the internal standard (IS). The analytes were extracted from rat plasma with acetonitrile and separated on a SB‐C₁₈ column (50 × 2.1 mm, i.d.; 1.8 µm) at 30 °C. Elution was achieved with a mobile phase consisting of methanol–water–formic acid (65:35:0.1, v/v/v) at a flow rate of 0.30 mL/min. Detection and quantification for analytes were performed by mass spectrometry in the multiple reaction monitoring mode with positive electrospray ionization m/z at 357.1 → 178.1 for kadsurenone, and m/z 345.1 → 315.1 for IS. Calibration curves were linear over a concentration range of 4.88–1464 ng/mL with a lower limit of quantification of 4.88 ng/mL. The intra‐ and inter‐day accuracies and precisions were <8.9%. The LC‐MS/MS assay was successfully applied for oral pharmacokinetic evaluation of kadsurenone using the rat as an animal model. Copyright © 2013 John Wiley & Sons, Ltd.     

Stereoselective determination of ginsenosides Rg3 and Rh2 epimers in rat plasma by LC‐MS/MS: Application to a pharmacokinetic study

We developed and validated an accurate and sensitive LC–MS/MS method for the simultaneous quantitation of ginsenoside Rg3 and Rh2 epimers (R‐Rg3, S‐Rg3, R‐Rh2, and S‐Rh2) in rat plasma. Analytes were extracted from 0.1 mL aliquots of rat plasma by liquid–liquid extraction, using 2 mL of ethyl acetate. In this assay, dioscin (500 ng/mL) was used as an internal standard. Chromatographic separation was conducted using an Acclaim RSLC C₁₈ column (150 × 2.1 mm, 2.2 μm) at 40°C, with a gradient mobile phase consisting of 0.1% formic acid in distilled water and in acetonitrile, a flow rate of 0.35 mL/min, and a total run time of 20 min. Detection and quantification were performed using a mass spectrometer in selected reaction‐monitoring mode with negative electrospray ionization at m/z 783.4 → 161.1 for R‐Rg3 and S‐Rg3, m/z 621.3 → 161.1 for R‐Rh2 and S‐Rh2, and m/z 867.2 → 761.5 for the internal standard. For R‐Rg3 and S‐Rg3, the lower limit of quantification was 5 ng/mL, with a linear range up to 500 ng/mL; for R‐Rh2 and S‐Rh2, the lower limit of quantification was 150 ng/mL, with a linear range up to 6000 ng/mL. The coefficient of variation for assay precision was less than 10.5%, with an accuracy of 86.4–112%. No relevant cross‐talk or matrix effect was observed. The method was successfully applied to a pharmacokinetic study after oral administration of 400 mg/kg and 2000 mg/kg of BST204, a fermented ginseng extract, to rats. We found that the S epimers exhibited significantly higher plasma concentrations and area under curve values for both Rg3 and Rh2. This is the first report on the separation and simultaneous quantification of R‐Rg3, S‐Rg3, R‐Rh2, and S‐Rh2 in rat plasma by LC‐MS/MS. The method should be useful in the clinical use of ginseng or its derivatives.     

Measurement of fexofenadine concentration in micro‐sample human plasma by a rapid and sensitive LC‐MS/MS employing protein precipitation: application to a clinical pharmacokinetic study

A simple, rapid and sensitive liquid chromatography/positive ion electro‐spray tandem mass spectrometry method (LC‐MS/MS) was developed and validated for the quantification of fexofenadine with 100 μL human plasma employing glipizide as internal standard (IS). Protein precipitation was used in the sample preparation procedure. Chromatographic separation was achieved on a reversed‐phase C₁₈ column (5 μm, 100 × 2.1 mm) with methanol : buffer (containing 10 mmol/L ammonium acetate and 0.1% formic acid; 70 : 30, v/v) as mobile phase. The total chromatographic runtime was approximately 3.0 min with retention time for fexofenadine and IS at approximately 1.9 and 2.1 min, respectively. Detection of fexofenadine and IS was achieved by LC‐MS/MS in positive ion mode using 502.1 → 466.2 and 446.0 → 321.1 transitions, respectively. The method was proved to be accurate and precise at linearity range of 1–600 ng/mL with a correlation coefficient (r) of ≥0.9976. The validated method was applied to a pharmacokinetic study in human volunteers following oral administration of 60 or 120 mg fexofenadine formulations, successfully. Copyright © 2009 John Wiley & Sons, Ltd.     

Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers

A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC/MS/MS) method to determine levonorgestrel in human plasma was developed and fully validated. After hexane-ethyl acetate (70:30, v/v) induced extraction from the plasma samples, levonorgestrel was subjected to LC/MS/MS analysis using electro-spray ionization. The MS system was operated in the selected reaction monitoring mode. Chromatographic separation was performed on a Hypersil BDS C18 column (i.d. 2.1x50 mm, particle size 3 microm). The method had a chromatographic running time of 2.0 min and linear calibration curves over the concentration ranges of 0.25-90 ng/mL for levonorgestrel. The lower limit of quantification of the method was 0.25 ng/mL for levonorgestrel. The intra- and inter-batch precision was 3.7-10.2 and 5.1-12.9%, respectively, for all quality control samples at concentrations of 0.5, 6.0 and 45.0 ng/mL. These results indicate that the method was efficient with a simple preparation procedure and a very short running time (2.0 min) for levonorgestrel compared with those methods reported in the literature and had high selectivity, acceptable accuracy, precision and sensitivity. The validated LC/MS/MS method was successfully used for a bioequivalence study of two tablet formulations of levonorgestrel in healthy volunteers.     

A liquid chromatography-mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens

A liquid chromatographic-mass spectrometry (LC/MS) assay method was developed for the determination of amiodarone and desethylamiodarone in rat specimens. Analytes were extracted using liquid-liquid extraction in hexane. The LC/MS system consisted of a Waters Micromass ZQtrade mark 4000 spectrometer with an autosampler and pump. A C(18) 3.5 microm (2.1 x 50 mm) column heated to 45 degrees C was used for separation. The mobile phase consisted of methanol and 0.2% aqueous formic acid pumped at 0.2 mL/min as a linear gradient. Components eluted within 12 min. The concentrations of ethopropazine (internal standard), desethylamiodarone and amiodarone were monitored for m/z of 313.10, combination of 546.9 and 617.73, and 645.83, respectively. In plasma (0.1 mL), linearity was achieved between the peak area ratios and concentrations over the range of 2.5-1000 ng/mL for both amiodarone and desethylamiodarone (r(2) > 0.999). The intraday and interday CV were equal or less than 18%, and mean error was <12%. Similarly, in homogenates containing 0.1 g of rat tissue, linearity was observed in standards ranging from 5 to 5000 ng/g. The method was successfully used to measure tissue and plasma concentrations of drug. The validated lower limit of quantitation was 2.5 ng/mL for drug and metabolite, based on 0.1 mL of plasma.     

Simultaneous determination of docetaxel and ketoconazole in rat plasma by liquid chromatography/electrospray ionization tandem mass spectrometry

A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed and validated for simultaneous quantification of docetaxel and ketoconazole in rat plasma with paclitaxel as internal standard (IS). The analytes were extracted from rat plasma by using a liquid-liquid extraction technique with ethyl acetate and the LC separation was performed on a Cosmosil-C(18) analytical column (150 mm x 2.0 mm i.d., Nacalai Tesque Inc., Japan). The extracted samples were analyzed with LC/MS/MS, operating in selected reaction monitoring (SRM) mode. The SRM transitions of precursor ions to product ions were 830.3-->549.1 (m/z) for docetaxel, 531.2-->489.3 (m/z) for ketoconazole, and 876.7-->307.9 (m/z) for the IS. The calibration curves were linear over the range of 2-500 ng/mL for docetaxel and 50-20 000 ng/mL for ketoconazole, with coefficients of correlation above 0.999. The limits of quantification for docetaxel and ketoconazole were both 2 ng/mL. The limit of detection for each analyte was 1 ng/mL. The intra- and inter-day precision (CV) of analysis were within 7%, and the accuracy ranged from 95 to 110%. The overall recoveries for docetaxel and ketoconazole were about 89.0% and 91.1%, respectively. The total analysis time was only 9.0 min. This quantitation method was successfully applied to the simultaneous determination of docetaxel and ketoconazole in rat plasma and some potential interaction was found in the current coadministration pharmacokinetic study. This established method was also utilized in the in vitro and in vivo drug-drug interaction study of docetaxel and ketoconazole (to be published).     

Highly sensitive determination of Schisandrin and Schisandrin B in plasma of rats after administration of Wurenchun (Fructus Schisandrae Chinensis Extracts) preparations by LC‐ESI‐MS/MS

A sensitive and specific method based on liquid chromatography‐tandem mass spectrometry using electrospray ionization (LC‐ESI‐MS/MS) has been developed for the determination of Schisandrin and Schisandrin B in rat plasma. A 100 μL plasma sample was extracted by methyl tert‐butyl ether after spiking the samples with nimodipine (internal standard) and performed on an XTerra®MS‐C₁₈ column (150 mm × 2.1 mm, 3.5 μm) with the mobile phase of acetonitrile–water–formic acid (80:20:0.2, v/v) at a flow rate of 0.2 mL/min in a run time of 8.5 min. The lower limit of quantification of the method was 40 ng/mL for Schisandrin and 20 ng/mL for Schisandrin B. The method showed reproducibility with intra‐day and inter‐day precision of less than 13.8% RSD, as well as accuracy, with inter‐ and intra‐assay accuracies between 93.5 and 107.2%. Finally, the LC‐ESI‐MS/MS method was successfully applied to study the pharmacokinetics of Schisandrin and Schisandrin B in rats after administration of Wurenchun commercial formulations to rats. Copyright © 2009 John Wiley & Sons, Ltd.